MRIGlobal announces the deployment of specialized mobile clinical diagnostics laboratories designed and developed for use in Ebola treatment centers in Sierra Leone. MRIGlobal's contract is with the Defense Threat Reduction Agency for two clinical diagnostic laboratories, outfitted with analytical equipment to quickly and accurately process samples to diagnose Ebola. These self-contained units include generators for powering the state-of-the-art facilities, along with systems for communications, clean water, storage, and living quarters.
"MRIGlobal proudly joins the national response against the Ebola epidemic," says Thomas M. Sack, PhD, president and CEO of MRIGlobal. "Our unique expertise in the design, development, and deployment of mobile systems is a valuable asset to the nation's Ebola response."
The completed labs will be transported from MRIGlobal in North Kansas City and loaded onto an Antonov An-124 Ruslan, a strategic airlift jet aircraft bound for Sierra Leone.
MRIGlobal has more than a decade of expertise in the design, development, and deployment of state-of-the-art mobile laboratories and related systems. Incorporating highly efficient electrical mini-grids, and ruggedized equipment, the mobile systems can be rapidly assembled or disassembled for transport.
"One of the most challenging aspects of Ebola is rapid diagnosis. Currently, it may take days for patient specimens to travel great distances to reference labs for diagnosis," Sack says. "Our labs bring the reference labs to the field enabling quick diagnosis. That means healthcare workers can quickly isolate Ebola patients, a critical step to decrease exposure and institute treatment protocols."
Source: MRIGlobal
CDC Strategies Preventing Hospital-Onset C difficile Effectiveness Inconclusive in Testing
April 15th 2024Hospitals using CDC prevention strategies had different incidences of hospital-associated Clostridioides difficile infection compared to those that didn't, but the reasons are not necessarily the strategies themselves.